Clark Estates’s Meridian Bioscience VIVO Stock Holding History
Bought
Maintained
Sold
Other funds holding VIVO
Clark Estates's VIVO Position: Q1 2022 in Review
Clark Estates sold out of Meridian Bioscience (VIVO) in Q1 2022, closing a stake of 220,000 shares — an estimated $4.49M sold.
Clark Estates first reported a position in VIVO in Q1 2017 and held it in 10 quarters. The position peaked at $5.78M in Q1 2021. 207 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.
- Clark Estates reported no remaining Meridian Bioscience position as of Q1 2022 after selling out during the quarter.
- Clark Estates sold 220,000 Meridian Bioscience shares in Q1 2022, an estimated $4.49M.
- Clark Estates first reported a position in Meridian Bioscience in Q1 2017 and held it in 10 quarters.
- Clark Estates's Meridian Bioscience position peaked at $5.78M in Q1 2021.
- 207 funds tracked by Wall St. Rank held Meridian Bioscience as of Q1 2022.
Based on Clark Estates's 13F filing for Q1 2022, filed 13 May 2022.